What are the treatment options for Irritable Bowel Syndrome (IBS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Irritable Bowel Syndrome (IBS)

Treatment of IBS should follow a step-wise approach, starting with dietary modifications and lifestyle changes, followed by targeted pharmacological interventions based on predominant symptoms, and psychological therapies for refractory cases. 1

Dietary and Lifestyle Modifications (First-Line)

  • Soluble fiber supplementation: Start with ispaghula (psyllium) at 3-4g/day and gradually increase for constipation symptoms 1
  • Low FODMAP diet: Recommended for moderate to severe symptoms, implemented by a trained dietitian 1
  • Symptom diary: Use to identify triggers and monitor treatment response 1
  • Avoid gas-producing foods: Reduce intake of foods high in fiber, lactose, or fructose 1
  • Mediterranean diet: Consider for patients with psychological-predominant symptoms 1

Pharmacological Treatment by Predominant Symptom

For Abdominal Pain

  1. Antispasmodics (e.g., dicyclomine): First-line treatment for abdominal pain 1
  2. Peppermint oil: Effective for pain relief 1
  3. Tricyclic antidepressants (e.g., amitriptyline 10-50mg at bedtime): For pain with sleep disturbance 1

For IBS with Diarrhea (IBS-D)

  1. Loperamide: Initial dose of 4 mg followed by 2 mg every 4 hours or after every unformed stool (max 16 mg/day) 1
  2. Codeine: 15-30 mg, 1-3 times daily as a second-line agent (caution: may cause sedation) 1
  3. Alosetron: For severe IBS-D that hasn't responded to other treatments 1
  4. Rifaximin: 550mg twice daily for 1-2 weeks if small intestinal bacterial overgrowth (SIBO) is suspected 1

For IBS with Constipation (IBS-C)

  1. Linaclotide: FDA-approved secretagogue for IBS-C with proven efficacy in clinical trials 2
    • Clinical trials showed 12-13% response rate (vs. 3-5% for placebo) for combined symptom improvement 2
    • 34-39% of patients experienced ≥30% reduction in abdominal pain (vs. 20-27% for placebo) 2
  2. Polyethylene glycol: Add if inadequate response to fiber 1

Psychological Therapies (For Refractory Symptoms)

  • Cognitive Behavioral Therapy (CBT): Effective in 4-12 sessions, focusing on pain catastrophizing and visceral anxiety 1
  • Gut-directed hypnotherapy: Focuses on somatic awareness and down-regulation of pain sensations 1
  • Mindfulness-based stress reduction: Improves specific symptoms like constipation, diarrhea, bloating, and gastrointestinal-specific anxiety 1

Treatment Algorithm

  1. Initial approach: Dietary modifications and lifestyle changes
  2. Add: Soluble fiber and/or peppermint oil
  3. If inadequate response: Add polyethylene glycol for constipation or loperamide for diarrhea
  4. If still inadequate response: Add a secretagogue (linaclotide preferred for IBS-C based on efficacy) 1, 2
  5. For persistent symptoms: Add an antispasmodic or gut-brain neuromodulator (tricyclic antidepressants, SNRIs, or SSRIs)
  6. For severe or refractory symptoms: Consider psychological therapies and multidisciplinary approach 1

Important Considerations

  • Set realistic expectations: Complete symptom resolution is often not achievable; efficacy of all IBS treatments is modest 1
  • Regular monitoring: Review efficacy after 3 months and discontinue ineffective treatments 1
  • Specialist referral: Consider referral to a gastroenterologist when diagnostic uncertainty exists, symptoms are severe or refractory to first-line treatments 1
  • Brain-gut axis: Anxiety, catastrophizing, and hypervigilance contribute to symptom severity and should be addressed 1
  • Coordination of care: For patients with mental health comorbidities, coordination between gastroenterology and mental health providers is essential 1

References

Guideline

Gastrointestinal Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.